Bladder Cancer in 2010 How Far Have We Come?

被引:290
作者
Jacobs, Bruce L. [1 ]
Lee, Cheryl T. [2 ]
Montie, James E. [3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15213 USA
[2] Director Bladder Canc Program, Dept Urol, Ann Arbor, MI 48109 USA
[3] Taubman Ctr, Dept Urol, Ann Arbor, MI 48109 USA
关键词
TRANSITIONAL-CELL-CARCINOMA; BACILLUS-CALMETTE-GUERIN; INVASIVE UROTHELIAL CARCINOMA; LYMPH-NODE DISSECTION; COLONY-STIMULATING FACTOR; PHASE-II TRIAL; REPEAT TRANSURETHRAL RESECTION; INDUCED FLUORESCENCE DIAGNOSIS; ASSISTED RADICAL CYSTECTOMY; INTRAVESICAL MITOMYCIN-C;
D O I
10.3322/caac.20077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high-risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010;60:244-272. (C) 2010 American Cancer Society, Inc.
引用
收藏
页码:244 / 272
页数:29
相关论文
共 245 条
  • [1] SMALL-CELL CARCINOMA OF THE BLADDER AND PROSTATE
    ABBAS, F
    CIVANTOS, F
    BENEDETTO, P
    SOLOWAY, MS
    [J]. UROLOGY, 1995, 46 (05) : 617 - 630
  • [2] Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
    Abol-Enein, H
    Bassi, P
    Boyer, M
    Coppin, CML
    Cortesi, E
    Grossman, HB
    Hall, RR
    Horwich, A
    Malmström, PU
    Martinez-Piñeiro, JA
    Sengelov, L
    Sherif, A
    Wallace, DMA
    Bono, AV
    Goebell, PJ
    Groshen, S
    Torti, FM
    Clarke, NW
    Roberts, JT
    Sylvester, R
    Parmar, MKB
    Stewart, LA
    Tierney, JF
    Vale, CL
    [J]. EUROPEAN UROLOGY, 2005, 48 (02) : 202 - 206
  • [3] Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
    Amin, Mahul B.
    [J]. MODERN PATHOLOGY, 2009, 22 : S96 - S118
  • [4] [Anonymous], 2004, UROLOGY
  • [5] [Anonymous], 2009, SEER Cancer Statistics Review, 1975-2006
  • [6] [Anonymous], SMOK CANC MORT TABL
  • [7] [Anonymous], 2002, AJCC Cancer Staging Manual
  • [8] [Anonymous], J UROL
  • [9] Arslan Halil, 2006, Int. braz j urol., V32, P147, DOI 10.1590/S1677-55382006000200004
  • [10] Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial
    Au, JLS
    Badalament, RA
    Wientjes, MG
    Young, DC
    Warner, JA
    Venema, PL
    Pollifrone, DL
    Harbrecht, JD
    Chin, JL
    Lerner, SP
    Miles, BJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) : 597 - 604